The impact of more restrictive hydrocodone rescheduling on unintentional pediatric opioid exposures
- PMID: 38783553
- DOI: 10.1002/pds.5793
The impact of more restrictive hydrocodone rescheduling on unintentional pediatric opioid exposures
Abstract
Purpose: To evaluate the impact of rescheduling hydrocodone combination products (HCPs) from schedule III of the Controlled Substances Act to the more restrictive schedule II on unintentional pediatric exposures (≤5 years old).
Methods: Using U.S. data on outpatient retail pharmacy dispensing, emergency department (ED) visits, and poison center (PC) exposure cases, we assessed trends in prescriptions dispensed and unintentional pediatric exposure cases involving hydrocodone (rescheduled from III to II) compared to oxycodone (schedule II) and codeine (schedule III for combination products) using descriptive and interrupted time-series (ITS) analyses during the 16 quarters before and after the October 2014 rescheduling of HCPs.
Results: Dispensing of hydrocodone products was declining before rescheduling but declined more steeply post-rescheduling. In ITS analyses, both hydrocodone and oxycodone had significant slope decreases in PC case rates in the post versus pre-period that was larger for hydrocodone, while codeine had a small but significant slope increase in PC case rates. An estimated 4202 ED visits for pediatric hydrocodone exposures occurred in the pre-period and 2090 visits occurred in the post-period, a significant decrease of 50.3%. Oxycodone exposures showed no significant decrease.
Conclusions: Pediatric hydrocodone unintentional exposure ED visits and PC cases decreased after HCP rescheduling more than would be expected had the pre-rescheduling trend continued; the acceleration in the decrease in hydrocodone PC cases was partially offset by a slowing in the decrease in codeine-involved cases. The trend changes were likely due to multiple factors, including changes in dispensing that followed the rescheduling. Unintentional pediatric medication exposures and poisonings remain a public health concern requiring ongoing, multifaceted mitigation efforts.
Keywords: child; codeine; hydrocodone; opioid epidemic/trends; oxycodone; pediatric; poisoning.
Published 2024. This article is a U.S. Government work and is in the public domain in the USA.
Similar articles
-
Trends in hydrocodone combination product exposures reported to California Poison Control System (CPCS) following DEA rescheduling.Clin Toxicol (Phila). 2021 Apr;59(4):313-319. doi: 10.1080/15563650.2020.1803350. Epub 2020 Aug 25. Clin Toxicol (Phila). 2021. PMID: 32840386 Free PMC article.
-
The impact of hydrocodone rescheduling on utilization, abuse, misuse, and overdose deaths.Pharmacoepidemiol Drug Saf. 2023 Jul;32(7):735-751. doi: 10.1002/pds.5603. Epub 2023 Feb 27. Pharmacoepidemiol Drug Saf. 2023. PMID: 36779261 Free PMC article.
-
Evaluation of opioid prescribing after rescheduling of hydrocodone-containing products.Am J Health Syst Pharm. 2017 Dec 15;74(24):2046-2053. doi: 10.2146/ajhp160548. Am J Health Syst Pharm. 2017. PMID: 29222361
-
Effects of hydrocodone rescheduling on opioid use outcomes: A systematic review.J Am Pharm Assoc (2003). 2021 Mar-Apr;61(2):e20-e44. doi: 10.1016/j.japh.2020.09.013. Epub 2020 Oct 27. J Am Pharm Assoc (2003). 2021. PMID: 33127312
-
Hydrocodone.2020 Nov 24. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2020 Nov 24. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31644010 Free Books & Documents. Review.
References
REFERENCES
-
- Wang GS, Olsen H, Severtson G, Green JL, Dart RC. The impact of the prescription opioid epidemic on young children: trends and mortality. Drug Alcohol Depend. 2020;211:107924.
-
- Lovegrove MC, Weidle NJ, Geller AI, et al. Trends in emergency department visits for unsupervised pediatric medication exposures. Am J Prev Med. 2023;64(6):834‐843.
-
- Burghardt LC, Ayers JW, Brownstein JS, Bronstein AC, Ewald MB, Bourgeois FT. Adult prescription drug use and pediatric medication exposures and poisonings. Pediatrics. 2013;132(1):18‐27.
-
- Karami S, Ajao A, Wong J, et al. The impact of hydrocodone rescheduling on utilization, abuse, misuse, and overdose deaths. Pharmacoepidemiol Drug Saf. 2023;32(7):735‐751.
-
- United States Drug Enforcement Administration. Drug Scheduling. https://www.dea.gov/drug‐information/drug‐scheduling. Accessed 6/10/2022.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous